BACKGROUND: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in the United Kingdom. Patients with lung cancer typically present with symptoms to general practitioners several times before referral or investigation. METHODS: We undertook a mixed methods feasibility individually randomised controlled trial (the ELCID trial) to assess the feasibility and inform the design of a definitive, fully powered, UK-wide, Phase III trial of lowering the threshold for urgent investigation of suspected lung cancer. Patients over 60, with a smoking history, presenting with new chest symptoms to primary care, were eligible to be randomised to intervention (urgent chest X-ray) or usual care. RESULTS: The trial design and mat...
Introduction Rapid and early diagnosis is are important factors in determining outcomes in lung canc...
Background The ELCID Trial is a feasibility randomised controlled trial examining the effect on lu...
INTRODUCTION: Lung cancer is the most common cancer worldwide, with 1.3 million new cases diagnosed ...
Background: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in th...
Background Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in the...
Background: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in th...
BACKGROUND: In order to improve lung cancer survival in the UK, a greater proportion of resectable c...
Published onlineJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tBACKGROUND...
Early diagnosis of lung cancer (LC) is a policy priority. However, symptoms are vague, associated wi...
Background Most individuals with lung cancer have symptoms for several months before presenting to t...
Early diagnosis of lung cancer (LC) is a policy priority. However, symptoms are vague, associated wi...
© Queen’s Printer and Controller of HMSO 2016.Background: Lung cancer kills more people than any oth...
Background: Lung cancer is a leading cause of mortality worldwide, and England has poorer outcomes c...
Lung cancer is common and survival rates poor, particularly in the United Kingdom, where late stage ...
Background: Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). E...
Introduction Rapid and early diagnosis is are important factors in determining outcomes in lung canc...
Background The ELCID Trial is a feasibility randomised controlled trial examining the effect on lu...
INTRODUCTION: Lung cancer is the most common cancer worldwide, with 1.3 million new cases diagnosed ...
Background: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in th...
Background Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in the...
Background: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in th...
BACKGROUND: In order to improve lung cancer survival in the UK, a greater proportion of resectable c...
Published onlineJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tBACKGROUND...
Early diagnosis of lung cancer (LC) is a policy priority. However, symptoms are vague, associated wi...
Background Most individuals with lung cancer have symptoms for several months before presenting to t...
Early diagnosis of lung cancer (LC) is a policy priority. However, symptoms are vague, associated wi...
© Queen’s Printer and Controller of HMSO 2016.Background: Lung cancer kills more people than any oth...
Background: Lung cancer is a leading cause of mortality worldwide, and England has poorer outcomes c...
Lung cancer is common and survival rates poor, particularly in the United Kingdom, where late stage ...
Background: Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). E...
Introduction Rapid and early diagnosis is are important factors in determining outcomes in lung canc...
Background The ELCID Trial is a feasibility randomised controlled trial examining the effect on lu...
INTRODUCTION: Lung cancer is the most common cancer worldwide, with 1.3 million new cases diagnosed ...